Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ONCOGENE AS
AS
Active
Org 825818642
Gunnar Randers' Vei 12, 2007
Kjeller
Technical testing and analysis
·
NACE 7120
Est. 2020 · 5 years old
2 employees
oncogene.no
Monitor
Share
Norway
/
Companies
/
Technical testing and analysis
/
ONCOGENE AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MB
Morten Bjelke-Holtermann Duesund
Chief Executive Officer
Chief Executive Officer
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
TH
Tore Helge Rismyhr
Board of Directors
Board of Directors
2024
KH
Klaus Hermann Beiske
Board of Directors
Board of Directors
2024
Former (1)
CK
Charitra Kumar Mishra
Chairman
Chairman
2020 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Modus I As
Company
72%
72%
2025
Econto As
Company
10%
10%
2025
Makri Invest As
Company
5%
5%
2025
Ida Christine Filtenborg Hansen
Individual
5%
5%
2025
Tore Helge Rismyhr
Individual
5%
5%
2025
Binita Debnath
Individual
3%
3%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ONCOGENE AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network